» Articles » PMID: 23642249

Engineered Culture Models for Studies of Tumor-microenvironment Interactions

Overview
Publisher Annual Reviews
Date 2013 May 7
PMID 23642249
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Heterogeneous microenvironmental conditions play critical roles in cancer pathogenesis and therapy resistance and arise from changes in tissue dimensionality, cell-extracellular matrix (ECM) interactions, soluble factor signaling, oxygen as well as metabolic gradients, and exogeneous biomechanical cues. Traditional cell culture approaches are restricted in their ability to mimic this complexity with physiological relevance, offering only partial explanation as to why novel therapeutic compounds are frequently efficacious in vitro but disappoint in preclinical and clinical studies. In an effort to overcome these limitations, physical sciences-based strategies have been employed to model specific aspects of the cancer microenvironment. Although these strategies offer promise to reveal the contributions of microenvironmental parameters on tumor initiation, progression, and therapy resistance, they, too, frequently suffer from limitations. This review highlights physicochemical and biological key features of the tumor microenvironment, critically discusses advantages and limitations of current engineering strategies, and provides a perspective on future opportunities for engineered tumor models.

Citing Articles

Direct current electrical fields inhibit cancer cell motility in microchannel confinements.

Naggay B, Farahani S, Gao X, Holle A, Kemkemer R Sci Rep. 2025; 15(1):4605.

PMID: 39920207 PMC: 11806051. DOI: 10.1038/s41598-025-87737-7.


Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing.

Perucca A, Llonin A, Benach O, Hallopeau C, Rivas E, Linares J Nat Commun. 2025; 16(1):1279.

PMID: 39900918 PMC: 11790944. DOI: 10.1038/s41467-025-56275-1.


Application of three-dimensional (3D) bioprinting in anti-cancer therapy.

Wu B, Wu Z, Hou Y, Fang Z, Deng Y, Wu H Heliyon. 2023; 9(10):e20475.

PMID: 37800075 PMC: 10550518. DOI: 10.1016/j.heliyon.2023.e20475.


Tumor interstitial fluid analysis enables the study of microenvironment-cell interactions in cancers.

Apiz Saab J, Muir A Curr Opin Biotechnol. 2023; 83:102970.

PMID: 37494818 PMC: 10528471. DOI: 10.1016/j.copbio.2023.102970.


Advances in Brain Metastasis Models.

Lee J, Yang S Brain Tumor Res Treat. 2023; 11(1):16-21.

PMID: 36762804 PMC: 9911715. DOI: 10.14791/btrt.2022.0037.


References
1.
Weaver V, Petersen O, Wang F, Larabell C, Briand P, Damsky C . Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol. 1997; 137(1):231-45. PMC: 2139858. DOI: 10.1083/jcb.137.1.231. View

2.
Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J . Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. PMC: 2788004. DOI: 10.1016/j.cell.2009.10.027. View

3.
Kenny P, Lee G, Myers C, Neve R, Semeiks J, Spellman P . The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol. 2008; 1(1):84-96. PMC: 2391005. DOI: 10.1016/j.molonc.2007.02.004. View

4.
Kikuchi A, Okano T . Pulsatile drug release control using hydrogels. Adv Drug Deliv Rev. 2002; 54(1):53-77. DOI: 10.1016/s0169-409x(01)00243-5. View

5.
Gill B, Gibbons D, Roudsari L, Saik J, Rizvi Z, Roybal J . A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model. Cancer Res. 2012; 72(22):6013-23. PMC: 3632398. DOI: 10.1158/0008-5472.CAN-12-0895. View